Sunday 6 April 2014

Phytochemical allicin and liver cancer

Allicin is phytochemical containing sulfur in the class of organosulfur compound, found abundantly in onion and garlic.
Liver cancer is defined as a condition of out of controlled growth of hepatocellular cells in the liver. Since the organ is a soft tissue with less nerve, most liver cancer patient are diagnosed in the later stage of the cancer. According to the statistic, liver cancer remains the fifth most common malignancy in men and the eighth in women worldwide.
Hepatocellular carcinoma (HCC) is a common form of primary liver cancer.


The health benefits
Hepatocellular carcinoma (HCC) is the most prevalent type of liver cancer in Southeast Asia. Anti cancer agent , although effective with many side effects. The urgency in finding of a natural treatment with little or no side effects has drawn many interest. Study showed that allicin induced degradation of cell death in human HCC Hep G2 (p53(wild type)) cells and apoptotic cell death through caspase-dependent and caspase-independent pathways by reactive oxygen species (ROS) overproduction in human cellular tumor antigen p53. on the other hand, Allicin treatment also found to induce apoptotic cell death in p53 knock down Hep G2 cells similar to that of Hep 3B cells. These results suggest that allicin  might be a potential novel complementary gene therapeutic agent for the treatment of apoptosis-resistant cancer cells.



Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months

Back to Most common Types of Cancer http://kylejnorton.blogspot.ca/p/blog-page.html

Back to Kyle J. Norton Home page http://kylejnorton.blogspot.ca

References
(1) Allicin induces anti-human liver cancer cells through the p53 gene modulating apoptosis and autophagy by Chu YL, Ho CT, Chung JG, Raghu R, Lo YC, Sheen LY.(PubMed)
(2) Allicin induces anti-human liver cancer cells through the p53 gene modulating apoptosis and autophagy by Chu YL, Ho CT, Chung JG, Raghu R, Lo YC, Sheen LY.(PubMed)

No comments:

Post a Comment